Austin-Based Savara Pharmaceuticals Raises $8.6 Million for New Clinical Trial
Austin-based Savara Pharmaceuticals raises .6 million for new clinical trial
Filed under: Austin Drug Treatment
Savara Pharmaceuticals, an Austin developer of drugs for cystic fibrosis patients, has raised $ 8.6 million to fund its next stage of clinical trials. The company said its drug, called AeroVanc, is the first inhaled antibiotic being developed for the …
Read more on Austin American-Statesman (blog)
UN report puts costs of proper global treatment of drug addicts at 0-250 …
Filed under: Austin Drug Treatment
VIENNA – Drug abuse worldwide is stagnant but still kills about 200000 people a year, the U.N.'s drug-fighting agency said in a report released Tuesday. Based on 2010 figures, the United Nations Office for Drugs and Crime also said global treatment for …
Read more on Minneapolis Star Tribune
Texas court overturns million drug judgment
Filed under: Austin Drug Treatment
AUSTIN, Texas (AP) — The Texas Supreme Court has reversed a nearly $ 5 million judgment against prescription drug maker Centocor Inc., that blamed the company for a Corpus Christi woman's illness after she took medication to treat an existing condition.
Read more on Houston Chronicle
Savara Pharmaceuticals Raises $8.6 Million In Series B …
Savara Pharmaceuticals Raises $8.6 Million in Series B Financing Round Austin, TX, June 12, 2012 – Savara Pharmaceuticals, an emerging specialty pharmaceutical company Patients Achieves Positive Results in Phase I Clinical Trial; 04/06/2012 Savara Pharmaceuticals … Access Full Source
Blog | CF Roundtable | A Newsletter For Adults With Cystic …
Savara Pharmaceuticals raises $8.6 million for new CF clinical trial of AeroVanc, the first inhaled antibiotic (vancomycin) for the treatment of staph http://www.statesman.com/blogs/content/shared-gen/blogs/austin/startups/entries/2012/06/13/austinbased_savara_pharmaceuti.html … Fetch Full Source
Savara Pharmaceuticals raises $8.6 million for New CF …
Savara Pharmaceuticals raises $8.6 million for new CF clinical trial of AeroVanc, the first inhaled antibiotic (vancomycin) for the treatment of staph http://www.statesman.com/blogs/content/shared-gen/blogs/austin/startups/entries/2012/06/13/austinbased_savara_pharmaceuti.html … Get Document
Infection – Silobreaker
AUSTIN, Texas — Savara Pharmaceuticals, an emerging specialty pharmaceutical company developing innovative pulmonary drugs for the treatment of serious and life-threatening conditions, today announced that it has raised $8.6 million in the in New Savara Pharmaceuticals Raises $8.6 Million Seri … Retrieve Content
Cystic Fibrosis | Latest From PR Newswire
Savara Pharmaceuticals Raises $8.6 Million in Series B Financing Round AUSTIN, Texas, June 12, 2012 /PRNewswire/ — Savara Pharmaceuticals, an emerging specialty pharmaceutical company developing founder of one of the most fast-paced specialties in modern clinical … Return Document
Texas Rare Earth Changes Board | NVMN's $2M Credit Line …
Savara Pharmaceuticals Raises $8.6 Million Series B Austin's Largest Multi-Family Project Coming to West Campus Area UH names architect for new stadium – Chron Solomon: Only certainty in Clemens trial is someone’s lying – Chron … Fetch Full Source